Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Short-term Investments (2016 - 2017)

Palisade Bio (PALI) has disclosed Short-term Investments for 4 consecutive years, with $5.0 million as the latest value for Q4 2017.

  • On a quarterly basis, Short-term Investments changed 0.0% to $5.0 million in Q4 2017 year-over-year; TTM through Dec 2017 was $5.0 million, a 0.0% change, with the full-year FY2017 number at $5.0 million, changed 0.0% from a year prior.
  • Short-term Investments was $5.0 million for Q4 2017 at Palisade Bio, roughly flat from $5.0 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $15.0 million in Q1 2015 to a low of $5.0 million in Q4 2016.
  • A 4-year average of $9.8 million and a median of $7.5 million in 2015 define the central range for Short-term Investments.
  • Biggest YoY gain for Short-term Investments was 0.22% in 2015; the steepest drop was 66.57% in 2015.
  • Palisade Bio's Short-term Investments stood at $15.0 million in 2014, then tumbled by 49.91% to $7.5 million in 2015, then crashed by 33.49% to $5.0 million in 2016, then changed by 0.0% to $5.0 million in 2017.
  • Per Business Quant, the three most recent readings for PALI's Short-term Investments are $5.0 million (Q4 2017), $5.0 million (Q3 2017), and $5.0 million (Q2 2017).